314 related articles for article (PubMed ID: 33785920)
21. The lightning-fast quest for COVID vaccines - and what it means for other diseases.
Ball P
Nature; 2021 Jan; 589(7840):16-18. PubMed ID: 33340018
[No Abstract] [Full Text] [Related]
22. SARS-CoV-2 SPIKE PROTEIN: an optimal immunological target for vaccines.
Salvatori G; Luberto L; Maffei M; Aurisicchio L; Roscilli G; Palombo F; Marra E
J Transl Med; 2020 Jun; 18(1):222. PubMed ID: 32493510
[TBL] [Abstract][Full Text] [Related]
23. A matter of priority: equitable access to COVID-19 vaccines.
Holzer F; Luna F; Manriquez T; Biller-Andorno N
Swiss Med Wkly; 2021 Mar; 151():w20488. PubMed ID: 33715145
[No Abstract] [Full Text] [Related]
24. Access considerations for a COVID-19 vaccine for South Africa.
Bangalee V; Suleman F
S Afr Fam Pract (2004); 2020 Oct; 62(1):e1-e4. PubMed ID: 33179954
[TBL] [Abstract][Full Text] [Related]
25. Why COVID vaccines are so difficult to compare.
Ledford H
Nature; 2021 Mar; 591(7848):16-17. PubMed ID: 33623151
[No Abstract] [Full Text] [Related]
26. The Cipro patent and bioterrorism.
Kaye KS; Kaye D
Am J Bioeth; 2002; 2(3):41-2. PubMed ID: 12230854
[No Abstract] [Full Text] [Related]
27. von der Leyen admits to COVID-19 vaccine failures.
Hyde R
Lancet; 2021 Feb; 397(10275):655-656. PubMed ID: 33610198
[No Abstract] [Full Text] [Related]
28. Multiepitope Subunit Vaccine Design against COVID-19 Based on the Spike Protein of SARS-CoV-2: An
Dar HA; Waheed Y; Najmi MH; Ismail S; Hetta HF; Ali A; Muhammad K
J Immunol Res; 2020; 2020():8893483. PubMed ID: 33274246
[TBL] [Abstract][Full Text] [Related]
29. COVID vaccination logistics: five steps to take now.
Teerawattananon Y; Dabak SV
Nature; 2020 Nov; 587(7833):194-196. PubMed ID: 33168970
[No Abstract] [Full Text] [Related]
30. Rationing of Civilian Coronavirus Disease 2019 Vaccines While Supplies Are Limited.
Zimmerman RK; South-Paul JE; Poland GA
J Infect Dis; 2020 Nov; 222(11):1776-1779. PubMed ID: 32894861
[No Abstract] [Full Text] [Related]
31. Withholding funding from the World Health Organization is wrong and dangerous, and must be reversed.
Nature; 2020 Apr; 580(7804):431-432. PubMed ID: 32303732
[No Abstract] [Full Text] [Related]
32. COVID-19 in the Caribbean.
Burki TK
Lancet Respir Med; 2021 Apr; 9(4):e46. PubMed ID: 33581745
[No Abstract] [Full Text] [Related]
33. Taking TRIPS to India--Novartis, patent law, and access to medicines.
Mueller JM
N Engl J Med; 2007 Feb; 356(6):541-3. PubMed ID: 17287473
[No Abstract] [Full Text] [Related]
34. COVID-19 Vaccine Distribution and Allocation: What Physicians Need to Know.
Laine C; Cotton D; Moyer DV
Ann Intern Med; 2021 Mar; 174(3):413-414. PubMed ID: 33492990
[TBL] [Abstract][Full Text] [Related]
35. International patent protection for HIV-related therapies: patent attorney's perspective.
Pavento LC; Greene JL; McDonald JK
Emory Int Law Rev; 2003; 17(2):919-31. PubMed ID: 15199935
[No Abstract] [Full Text] [Related]
36. mRNA Vaccines: Possible Tools to Combat SARS-CoV-2.
Yi C; Yi Y; Li J
Virol Sin; 2020 Jun; 35(3):259-262. PubMed ID: 32524253
[No Abstract] [Full Text] [Related]
37. Ensure Palestinians have access to COVID-19 vaccines.
Martin S; Arawi T
Lancet; 2021 Feb; 397(10276):791-792. PubMed ID: 33577758
[No Abstract] [Full Text] [Related]
38. Fast-and-fit vaccines.
Nat Biomed Eng; 2020 Aug; 4(8):757-758. PubMed ID: 32760006
[No Abstract] [Full Text] [Related]
39. A license to print money?
Nat Biotechnol; 2006 Jun; 24(6):593. PubMed ID: 16763570
[No Abstract] [Full Text] [Related]
40. COVID-19 vaccines and treatments nationalism: Challenges for low-income countries and the attainment of the SDGs.
Nhamo G; Chikodzi D; Kunene HP; Mashula N
Glob Public Health; 2021 Mar; 16(3):319-339. PubMed ID: 33317389
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
